The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group
Authors:
- Eleni FrangouEFEleni Frangou
- Andreas KronbichlerAKAndreas Kronbichler
- Stefanie SteigerStefanie Steiger
- Annette BruchfeldABAnnette Bruchfeld
- Fernando Caravaca-FontánFCFernando Caravaca-Fontán
- Safak MiriogluSMSafak Mirioglu
- Sarah MoranSMSarah Moran
- Luis F QuintanaLQLuis F Quintana
- Kate I StevensKSKate I Stevens
- Y K Onno TengYTY K Onno Teng
- Jürgen FloegeJFJürgen Floege
- Marina VivarelliMVMarina Vivarelli
Open Access
- 5 December 2025
- Vol. 19 (1)
Abstract
Despite advances and therapeutic progress, nephrotic syndrome (NS) in childhood remains challenging due to its heterogeneous presentation, variable response to treatment and the potential of adverse long-term kidney outcomes. The recently published KDIGO 2025 clinical practice guideline for the management of NS in children refines the definitions of relapse, infrequently- and frequently-relapsing NS and steroid-resistant NS. Herein we describe the revised definitions, summarize the key updates of the KDIGO 2025 guidelines and comment on the new treatment algorithm from a European viewpoint, highlighting the need for individualized approaches to minimize toxicity and optimize long-term kidney outcomes in NS in children.Keywords
This publication has 22 references indexed in Scilit:
- A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndromeKidney International, 2018
- Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndromePediatric Nephrology, 2017
- A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatmentKidney International, 2015
- Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndromeKidney International, 2015
- Extending Prednisolone Treatment Does Not Reduce Relapses in Childhood Nephrotic SyndromeJournal of the American Society of Nephrology, 2013
- Cyclophosphamide in steroid-dependent nephrotic syndromePediatric Nephrology, 2011
- Daily Corticosteroids Reduce Infection-associated Relapses in Frequently Relapsing Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2011
- Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trialArchives of Disease in Childhood, 2008
- Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infectionJournal of Paediatrics and Child Health, 2004
- Increased Maintenance Corticosteroids during Upper Respiratory Infection Decrease the Risk of Relapse in Nephrotic SyndromeNephron, 2000